Screening for impact of popular herbs improving mental abilities on the transcriptional level of brain transporters

Acta Pharmaceutica

Volumn 64, Issue 2, 2014, Pages 223-232

  Mrozikiewicz, Przemyslaw M ^a,b   Bogacz, Anna ^a,b   Bartkowiak Wieczorek, Joanna ^a,b   Kujawski, Radoslaw ^b   Mikolajczak, Przemyslaw L ^a,b   Ozarowski, Marcin ^a,b   Czerny, Boguslaw ^b,c   Mrozikiewicz Rakowska, Beata ^d   Grzeskowiak, Edmund ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

ABC proteins8P glycoprotein; Blood brain barrier; Expression level; Herbal substances

Indexed keywords

CODEINE; CYCLOSPORIN A; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; PHENOBARBITAL; PIRACETAM; QUERCETIN; VERAPAMIL; CARRIER PROTEIN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; GENE EXPRESSION; HERB; IN VIVO STUDY; MALE; MENTAL CAPACITY; MENTAL DISEASE; NONHUMAN; PLANT LEAF; RAT; ANIMAL; BRAIN; BRAIN NEOPLASMS; DRUG EFFECTS; GENETIC TRANSCRIPTION; GINKGO BILOBA; HYPERICUM; MEDICINAL PLANT; MENTAL DISORDERS; METABOLISM; PANAX; PHYSIOLOGY; PLANT ROOT; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; GINKGO BILOBA; HYPERICUM; MALE; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; PANAX; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; TRANSCRIPTION, GENETIC; VERAPAMIL;

EID: 84904202841     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/acph-2014-0020     Document Type: Article

References (27)

1. N. J. Abbott, Blood-brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis. 36 (2013) 437-449; DOI: 10.1007/s10545-013-9608-0.
2. L. A. Khawli and S. Prabhu, Drug delivery across the blood-brain barrier, Mol. Pharm. 10 (2013) 1471-1472; DOI: 10.1021/mp400170b.
3. A. H. Schinkel, J. J. Smith, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. Mol, M. A. van der Valk, E. C. Robanus-Maandag and H. P. te Riele, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell 77 (1994) 491-502; DOI: 10.1016/0092-8674(94)90212-7. (Pubitemid 24153990)
4. D. S. Miller, Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier, Trends Pharmacol. Sci. 31 (2010) 246-254; DOI: 10.1016/j.tips.2010.03.003.
5. J. Malmo, A. Sandvig, M. K. Varum and S. P. Strand, Nanoparticle mediated P-glikoprotein silencing for improved drug delivery across the blood-brain barrier: A siRNA-chitosan approach, PLoS ONE 8 (2013) e54182; DOI: 10.1371/journal.pone.0054182.
6. F. J. Sharom, ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics 9 (2008) 105-127; DOI: 10.2217/14622416.9.1. 105. (Pubitemid 351560534)
7. C. J. Bachmeier, W. J. Trickler and D. W. Miller, Comparison of drug efflux transport kinetics in various blood-brain barrier models, Drug Metab. Dispos. 34 (2006) 998-1003; DOI: 10.1124/dmd. 105.006999.
8. S. P. C. Cole, Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future, Annu. Rev. Pharmacol. Toxicol. 54 (2014) 95-117; DOI: 10.1146/annurev-pharmtox-011613- 135959.
9. S. A. Kliewer, The nuclear pregnane X receptor regulates xenobiotic detoxification, J. Nutr. 133 (2003) 2444S-2447S. (Pubitemid 36828852)
10. B. I. Sikic, Modulation of multidrug resistance: At the threshold, J. Clin. Oncol. 11 (1993) 1629-1635. (Pubitemid 23277312)
11. T. Eichhorn and T. Efferth, P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs, J. Ethnopharmacol. 141 (2012) 557-570; DOI: 10.1016/j.jep.2011.08.053.
12. O. Khantamat, W. Chaiwangyen and P. Limtrakul, Screening of flavonoids for their potential inhibitory effect on p-glycoprotein activity in human cervical carcinoma kb cells, Chiang Mai Med. Bull. 43 (2004) 45-56.
13. S. Zhou, L. Y. Lim and B. Chowbay, Herbal modulation of P-glycoprotein, Drug Metab. Rev. 36 (2004) 57-104. (Pubitemid 38387835)
14. P. Limtrakul, O. Khantamat and K. Pintha, Inhibition of P-glycoprotein function and expression by kaempferol and quercetin, J. Chemother. 17 (2005) 86-95; DOI: 10.1179/joc.2005.17.1.86.
15. European Pharmacopoeia, 6th ed., Vol. 2, Council of Europe, Strassbourg Cedex 2008.
16. T. Sugamo, K. Nakamura and H. Tamura, Effects of cytochrome P450 inducers on the gene expression of ocular xenobiotic metabolizing enzymes in rats, J. Health Sci. 55 (2009) 923-929; DOI: 10.1248/jhs.55.923.
17. U. Andersson, K. Grankvist, A. T. Bergenheim, P. Behnam-Motlagh, H. Hedman and R. Henriksson, Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation, Med. Oncol. 19 (2002) 1-9. (Pubitemid 34587751)
18. R. Zhang, J. Jie, Y. Zhou, Z. Cao and W. Li, Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo, Am. J. Chin. Med. 37 (2009) 657-667; DOI: 10.1142/S0192415X09007144.
19. J. Zhang, F. Zhou, X. Wu, Y. Gu, H. Ai, Y. Zheng, Y. Li, X. Zhang, G. Hao, J. Sun, Y. Peng and G. Wang, 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: A case for herb-drug interactions, Drug Metab. Dispos. 38 (2010) 2179-2187; DOI: 10.1124/dmd. 110.034793.
20. A. Kawase, A. Yamada, Y. Gamou, Ch. Tahara, F. Takeshita, K. Murata, H. Matsuda, K. Samukawa and M. Iwaki, Effects of ginsenosides on the expression of cytochrome P450s and transporters involved in cholesterol metabolism, J. Nat. Med. (2013); DOI 10.1007/s11418-013-0791-y.
21. M. Hennessy, D. Kelleher, J. P. Spiers, M. Barry, P. Kavanagh, D. Back, F. Mulcahy and J. Feely, St Johns wort increases expression of P-glycoprotein: implications for drug interactions, Br. J. Clin. Pharmacol. 53 (2002) 75-82; DOI: 10.1046/j.0306-5251.2001.01516.x. (Pubitemid 34117742)
22. C. C. Weber, S. Kressmann, G. Fricker and W. E. Muller, Modulation of P-glycoprotein function by St John's wort extract and its major constituents, Pharmacopsychiatry 37 (2004) 292-298; DOI: 10.1055/s-2004-832686. (Pubitemid 39587057)
23. Ch. Garrovo, A. Rosati, F. Bartoli and G. Decorti, St John's wort modulation and developmental expression of multidrug transporters in the rat, Phytother. Res. 20 (2006) 468-473; DOI: 10.1002/ ptr.1880.
24. L. Li, J. D. Stanton, A. H. Tolson, Y. Luo and H. Wang, Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways, Pharm. Res. 26 (2009) 872-882; DOI: 10.1007/s11095-008-9788-8.
25. G. Scambia, F. O. Ranelletti, P. B. Panici, R. De Vincenzo, G. Bonanno, G. Ferrandina, M. Piantelli, S. Bussa, C. Rumi, M. Cianfriglia and S. Mancuso, Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target, Cancer Chemoth. Pharm. 34 (1994) 459-464; DOI: 10.1371/journal.pone.0051764. (Pubitemid 24306043)
26. A. B. Shapiro and V. Ling, Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein, Biochem. Pharmacol. 53 (1997) 587-596; DOI: 10.1016/S0006-2952(96) 00826-X.
27. M. E. Morris and S. Zhang, Flavonoid-drug interactions: Effects of flavonoids on ABC transporters, Life Sci. 78 (2006) 2116-2130; DOI: 10.1016/j.lfs. 2005.12.003. 232